STOCK TITAN

Recursion to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Recursion (RXRX), a clinical stage TechBio company, has announced its participation in three major upcoming investor conferences in June 2025. The company will present at the Jefferies Global Healthcare Conference on June 5, the Goldman Sachs 46th Annual Global Healthcare Conference on June 10, and the TDCowen 4th Annual Tools/Dx Revolution Conference on June 23. Interested parties can access the webcasts of these presentations through the events section of Recursion's Investor Relations website at ir.recursion.com.
Recursion (RXRX), un'azienda TechBio in fase clinica, ha annunciato la sua partecipazione a tre importanti conferenze per investitori previste per giugno 2025. La società presenterà alla Jefferies Global Healthcare Conference il 5 giugno, alla Goldman Sachs 46th Annual Global Healthcare Conference il 10 giugno e alla TDCowen 4th Annual Tools/Dx Revolution Conference il 23 giugno. Gli interessati possono seguire le webcasting di queste presentazioni nella sezione eventi del sito Investor Relations di Recursion all'indirizzo ir.recursion.com.
Recursion (RXRX), una empresa TechBio en etapa clínica, ha anunciado su participación en tres importantes conferencias para inversores que se llevarán a cabo en junio de 2025. La compañía presentará en la Jefferies Global Healthcare Conference el 5 de junio, en la Goldman Sachs 46th Annual Global Healthcare Conference el 10 de junio y en la TDCowen 4th Annual Tools/Dx Revolution Conference el 23 de junio. Los interesados pueden acceder a las transmisiones en vivo de estas presentaciones a través de la sección de eventos del sitio web de Relaciones con Inversores de Recursion en ir.recursion.com.
임상 단계의 TechBio 기업인 Recursion(RXRX)은 2025년 6월에 열리는 세 개의 주요 투자자 컨퍼런스에 참여할 예정임을 발표했습니다. 회사는 6월 5일 Jefferies Global Healthcare Conference, 6월 10일 Goldman Sachs 46th Annual Global Healthcare Conference, 6월 23일 TDCowen 4th Annual Tools/Dx Revolution Conference에서 발표할 예정입니다. 관심 있는 분들은 Recursion 투자자 관계 웹사이트 ir.recursion.com의 이벤트 섹션을 통해 이 발표들의 웹캐스트를 시청할 수 있습니다.
Recursion (RXRX), une entreprise TechBio en phase clinique, a annoncé sa participation à trois grandes conférences pour investisseurs prévues en juin 2025. La société présentera lors de la Jefferies Global Healthcare Conference le 5 juin, de la Goldman Sachs 46th Annual Global Healthcare Conference le 10 juin, et de la TDCowen 4th Annual Tools/Dx Revolution Conference le 23 juin. Les personnes intéressées peuvent accéder aux webcasts de ces présentations via la section événements du site Relations Investisseurs de Recursion à l'adresse ir.recursion.com.
Recursion (RXRX), ein TechBio-Unternehmen in der klinischen Phase, hat seine Teilnahme an drei bedeutenden Investorenkonferenzen im Juni 2025 angekündigt. Das Unternehmen wird auf der Jefferies Global Healthcare Conference am 5. Juni, der Goldman Sachs 46th Annual Global Healthcare Conference am 10. Juni und der TDCowen 4th Annual Tools/Dx Revolution Conference am 23. Juni präsentieren. Interessierte können die Webcasts dieser Präsentationen über den Veranstaltungsbereich der Investor-Relations-Website von Recursion unter ir.recursion.com abrufen.
Positive
  • None.
Negative
  • None.

Salt Lake City, May 30, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in the following upcoming investor conferences:

  • Jefferies Global Healthcare Conference — Thursday, June 5, 2025
  • Goldman Sachs 46th Annual Global Healthcare Conference — Tuesday, June 10, 2025
  • TDCowen 4th Annual Tools/Dx Revolution Conference — Monday, June 23, 2025

Webcasts may be found in the events section of the Recursion Investor Relations website at ir.recursion.com.
About Recursion
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.
Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montréal, New York, London, Oxford area, and the San Francisco Bay area. Learn more at www.Recursion.com, or connect on X (formerly Twitter) and LinkedIn.



Investor Contact
Investor@Recursion.com

Media Contact
Media@Recursion.com

FAQ

When is Recursion (RXRX) presenting at the Jefferies Global Healthcare Conference 2025?

Recursion will present at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025.

Which investor conferences will Recursion (RXRX) attend in June 2025?

Recursion will attend three conferences: Jefferies Global Healthcare Conference (June 5), Goldman Sachs Global Healthcare Conference (June 10), and TDCowen Tools/Dx Revolution Conference (June 23).

How can investors access Recursion's (RXRX) conference presentations?

Investors can access the webcasts through the events section of Recursion's Investor Relations website at ir.recursion.com.

What is Recursion's (RXRX) business focus?

Recursion is a clinical stage TechBio company focused on decoding biology to radically improve lives.
Recursion Pharmaceuticals, Inc.

NASDAQ:RXRX

RXRX Rankings

RXRX Latest News

RXRX Stock Data

1.68B
379.41M
3.6%
77.01%
20.08%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SALT LAKE CITY